Literature DB >> 18230919

Hydroxyethyl starch inhibits endothelium-derived relaxation in porcine coronary arteries.

Oguzhan Dagtekin1, Henning Krep, Jürgen Hartmut Fischer.   

Abstract

OBJECTIVE: Hydroxyethyl starch (HES) solutions are widely used for fluid resuscitation. We studied the effects of HES on endothelium-dependent relaxation (EDR), especially on the endothelium-derived hyperpolarizing factor (EDHF).
METHODS: Four-millimeter-long rings of fresh porcine coronary arteries from the local slaughterhouse were consecutively tested with or without HES (6 mg/ml). Indomethacin (10 micromol/l) was added in all measurements to eliminate prostacyclin effects. Prostaglandin F2alpha (10 micromol/l) was used for contraction and bradykinin (10(-10) to 10(-5) mol/l) for inducing EDR, which was calculated in percentage of the precontraction. After blocking all nitric oxide formation by N-nitro-L-arginine (300 micromol/l), the experiments were repeated to assess the EDHF-mediated relaxation response to bradykinin.
RESULTS: HES 6 mg/ml induced a significant (p < 0.01) reduction in EDR (n = 8). After incubation with HES and nitric oxide blockage with N-nitro-L-arginine, the relaxation response was reduced especially for the bradykinin concentrations of 10(-6) mol/l (p < 0.05) and 10(-5) mol/l (p < 0.01).
CONCLUSION: For the clinically relevant concentration of 6 mg/ml HES, a significant reduction in EDR and the EDHF can be found in epicardial coronary arteries of the pig. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230919     DOI: 10.1159/000114448

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  1 in total

1.  Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis.

Authors:  Shariq A Khan; Owoicho Adogwa; Tong J Gan; Ulysses T Null; Terence Verla; Sankalp Gokhale; William D White; Gavin W Britz; Ali R Zomorodi; Michael L James; David L McDonagh
Journal:  Springerplus       Date:  2013-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.